Research On Financial Strategy Optimization Of Pharmaceutical Circulation Enterprises Under The Background Of "Two-vote System"

In January 2017,the National Health and Family Planning Commission and other departments officially announced the "Two-vote System" Opinions on Drug Purchasing(Trial),stipulating that the country must abide by the "Two-vote system" regulations.The "two-ticket system" will have a very direct impact on the circulation of drugs.It will reduce the circulation of drugs in the market and reduce the number of transfers of drugs to consumers.This can prevent drugs from being repeatedly raised during the circulation process.Price,which controls the final purchase price of the consumer.But this will definitely reduce the profits of the pharmaceutical industry and make the experience between the industries more and more intense.This article selects Kyushutong as the research object,and takes the basic theory of financial strategy as the research basis,and combines the internal and external environment of Kyushutong Pharmaceutical Group to conduct research from the optimization and implementation of financial strategy.First,the two-vote system and financial strategy-related theories were reviewed,and then PEST was used to describe the current macro situation of the pharmaceutical distribution industry from the political,economic,social,and technological environment.The SWOT analysis method was used to analyze the internal environment.The analysis of the company’s strengths,weaknesses,opportunities and threats summarizes the current status of the financial strategy and existing issues.Then,a series of data is used to elaborate on the development status of the pharmaceutical industry and the status quo of financial strategy,and summarize the status quo of financial strategy and existing problems.Finally,combined with the concepts of Kyushu Tong’s cash surplus and value management,and clarifying the development stage of the company by constructing a financial matrix,the shortcomings of Kyushu Tong Pharmaceutical Group’s investment strategy,fundraising strategy,and capital operation strategy were analyzed.On this basis,the optimization of financial strategies in investment,fundraising and capital operation of the company is proposed.In addition,in order to guarantee the implementation of financial strategy optimization,this article also puts forward specific safeguard measures for the implementation of financial strategy.This article combines the strategic analysis tool financial strategy matrix and financial strategy,and combines theory with practice to conduct in-depth research and discussion on theoptimization of pharmaceutical companies’ financial strategy.It has certain reference significance for other pharmaceutical companies to formulate and optimize financial strategies.